Indications

Femisitol capsule is indicated for the treatment and prevention of-
. Polycystic ovary syndrome (PCOS)
Anovulation
Menstrual disorders such as amenorrhea
. Hyperandrogenism complaints such as hirsutism,
. Alopecia, acanthosis nigricans, acne
. Ovarian hyperthecosis.

Composition

1 capsule (500 mg) contains-
. Energy Value: 1.9 Cal
Proteins: 0 mg
. Carbohydrates: ≥ 0.475 mg
. Sugars: ≥0.475 mg
. Total Fat: 0 mg
. Saturated Fat: 0 mg
Trans Fat: 0 mg
. Fiber: 0 mg
. Mineral (Sodium): ≤ 0.01 mg

Pharmacology

D-chiro-inositol is extracted by a patented process from Carob (Ceratonia siliqua) pod that mostly found in Southern Europe. Deficiency of D-chiro-inositol in peripheral tissue causes insulin resistance
that leads to hyperandrogenism in ovaries which results polycystic ovary syndrome (PCOS). D-chiro-inositol helps to regulate the balance between androgen and estrogen by decreasing luteinizing
hormone and serum testosterone level. It improves glucose tolerance and reduces circulating insulin. It reduces oxidative stress on follicle and decreases total cholesterol and triglyceride levels. D-
chiro-inositol has been clinically proven as an effective treatment of ovarian cyst and PCOS associated metabolic disorders. It helps to improve and regulate normal ovulation after two weeks of
administration. It also reduces hyperandrogenism related skin disorders like hirsutism, alopecia, acanthosis nigricans and acne. It lowers cardiovascular risk in women who are suffering from PCOS by
controlling arterial pressure.

Dosage & Administration

Orally 1-2 capsules daily or as advised by the physician. Duration of the treatment should be minimum 2 months

Interaction

Concurrent use with digoxin may result in increased digoxin toxicity.

Contraindications

Contraindicated in patient with known hypersensitivity to D-chiro-inositol.

Side Effects

Well tolerated in recommended dose.

Pregnancy & Lactation

Several human studies have been conducted with inositol has no clinically relevant adverse effects.